LY6D and ovarian cancer: High Ly6D mRNA expression in ovarian cancer was significantly correlated with poor outcome in five-year post progression free survival (low Ly6D, n=517; high Ly6D, n=190; HR=1.22, p=0.049) shown by KM plotter (Table S1, Figure 1D).